Alexia T. Gasparin
Curitiba, PR, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Hilab volt system for electrolyte measurement: a portable solution for point-of-care testing.
Journal: Scientific reports
Published: August 25, 2025
Clinical validation of the Hilab lens for AI supported point of care CBC testing in pediatric oncology.
Journal: Communications medicine
Published: March 06, 2025
Pharmacological Interaction Between Cannabidiol and Tramadol on Experimental Diabetic Neuropathic Pain: An Isobolographic Analysis.
Journal: Cannabis and cannabinoid research
Published: May 19, 2023
Hilab System Device in an Oncological Hospital: A New Clinical Approach for Point of Care CBC Test, Supported by the Internet of Things and Machine Learning.
Journal: Diagnostics (Basel, Switzerland)
Published: April 10, 2023
Cannabidiol enhances the antinociceptive effects of morphine and attenuates opioid-induced tolerance in the chronic constriction injury model.
Journal: Behavioural brain research
Published: June 29, 2022
Bixin attenuates mechanical allodynia, anxious and depressive-like behaviors associated with experimental diabetes counteracting oxidative stress and glycated hemoglobin.
Journal: Brain research
Published: January 18, 2021
Spinal cannabinoid CB1 or CB2 receptors activation attenuates mechanical allodynia in streptozotocin-induced diabetic rats.
Journal: Behavioural pharmacology
Published: August 18, 2020
Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors.
Journal: Brain research
Published: September 04, 2018
Acute antinociceptive effect of fish oil or its major compounds, eicosapentaenoic and docosahexaenoic acids on diabetic neuropathic pain depends on opioid system activation.
Journal: Behavioural brain research
Published: August 30, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026